
The latest research related to the treatment of patients with psoriatic arthritis is often first made public at the American College of Rheumatology (ACR) annual meeting. In this CME activity, Dr. Roy Fleischmann of the University of Texas Southwestern Medical Center at Dallas discusses three posters presented at ACR Convergence 2020. Dr. Fleischmann first summarizes the methods and results of each of these posters, then provides his own thoughts as to the importance of the research findings and implications for clinical practice in the treatment of patients with psoriatic arthritis.
Course Credit:
0.75 AMA PRA Category 1 CreditTM
Dates:
Opens: 2020-12-31
Closes: 2021-12-30
Target Audience:
This activity is intended for a national audience of rheumatologists, dermatologists, primary care physicians and other healthcare providers who manage patients with psoriatic arthritis.
This activity is supported by an educational grant from Janssen Biotech, Inc.
-
Roy M. Fleischmann, MD
Clinical Professor of Medicine
University of Texas Southwestern Medical Center
Medical Director
Metroplex Clinical Research Center
Dallas, Texas
Downloads
Learning Objectives
- Summarize the latest research developments in the treatment of psoriatic arthritis
- Describe how new data and recommendations can impact clinical practices to improve care
- Incorporate evidence-based research into clinical practice
Faculty Disclosures
Roy M. Fleischmann, MD
Consultant: AbbVie, Amgen, Eli Lilly, GSK, Pfizer, UCB
Research Support: AbbVie, Amgen, BMS, Eli Lilly, GSK, Pfizer, Sanofi, TEVA, UCB
Accreditation and Certification
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Additional Content Planners
Eugene Cullen, MD (Peer Reviewer)No significant relationship to disclose
Gregory Scott, PharmD, RPh (Medical Writer)
No significant relationships to disclose.
Annenberg Center for Health Sciences
All staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.